NFKB1 and cancer: Multiple studies investigating Selinexor have suggested that NEI causes EMT reversal in cancer cells, with inhibition of NFκB by IκBα playing a significant role (Kashyap et al., 2016a; Kashyap et al., 2016b; Galinski et al., 2021).